GRT, ADVS, VITA, MHO, GTXI, FISI Expected to Trade Up After Bullish Patterns Develop
May 31, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top technical trading patterns and these stocks are the most likely to trade Up in the coming weeks. GLIMCHER REALTY TRUST (NYSE:GRT), ADVENT SOFTWARE INC (NASDAQ:ADVS), ORTHOVITA INC (NASDAQ:VITA), M/I HOMES INC (NYSE:MHO), GTX INC (NASDAQ:GTXI), FINANCIAL INSTITUTIONS INC (NASDAQ:FISI) are all expected to go Up as Bullish signals have been generated by top technical trading patterns. We monitor these patterns: Support Break, Support Reversal, Breakaway Gap, Measured Gap, Exhaustion Gap, Resistance Break, Resistance Reversal, Saucer Reversal, Volume Climax, Volume Trend, Fibonacci Reversal, Consolidation Breaks, Trend Line Break,Trend Line Reversal, Candles, Golden Crosses, Death Crosses and more. The chart below displays the stocks expected to go Up along with pattern, strategy and strength ratings.
Symbol Company Strategy Pattern Name Strength GRT GLIMCHER REALTY TRUST Breakout (Stocks) DO Resistance Break(1) 5 ADVS ADVENT SOFTWARE INC Reversal (Stocks) DWC 38 % Retracement 4 VITA ORTHOVITA INC Reversal (Stocks) DWC Broadening Continuation 1 MHO M/I HOMES INC Reversal (Stocks) DWC Trend Line Break(2) 4 GTXI GTX INC Breakout (Stocks) DO Common Gap 3 FISI FINANCIAL INSTITUTIONS INC Reversal (Stocks) DWC Common Gap 3Chart Pattern Recognition is based on a 20-year patterns database. This database is used to determine pattern strength for patterns as they appear. There is no optimization and the pattern signals never change. For each pattern variation, we record accuracy and profitability statistics in a patterns database. From this information, we are able to define strength ratings from 1 to 5. The '1' rating shows ALL patterns while a '5' rating shows the best patterns according to profitability. Each pattern has its own strength rating factors. The result is an automatic ranking system that allows us to only show the BEST patterns. You can see that, at Strength 5, virtually all the patterns are profitable. The pattern strength rating system separates the most profitable patterns. The specific technology used to make these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/sw/ot.php
GLIMCHER REALTY TRUST (NYSE:GRT) - Glimcher Realty Trust operates as a real estate investment trust (REIT) in the United States. It owns, leases, acquires, develops, and operates a portfolio of retail properties, including regional and super regional malls, as well as community shopping centers. As of December 31, 2007, the company managed and leased 27 properties, including 23 malls and 4 community centers located in the states of Ohio, West Virginia, California, Florida, North Carolina, Pennsylvania, Kansas, Kentucky, Minnesota, New Jersey, Oklahoma, Oregon, Tennessee, and Washington. Glimcher Realty Trust has elected to be taxed as a REIT and would not be subject to corporate income tax on that portion of its net income that is distributed to shareholders. The company was founded in 1993 and is headquartered in Columbus, Ohio.
ADVENT SOFTWARE INC (NASDAQ:ADVS) - Advent Software, Inc. provides software and services that automate work flows and data across investment management organizations, as well as the information flows between an investment management organization and external parties. The company develops, markets, and sells stand-alone and client/server software products, hosting services, data and data interfaces, and related maintenance and services that automate, integrate, and support the functions of the front, middle, and back offices of investment management organizations. It also provides professional services, such as consulting, project management, implementation, integration, custom report writing, and training. The companys clients include asset managers, registered investment advisors, prime brokers, fund administrators, hedge funds, family offices, broker dealers, foundations, endowments, fund of funds, and wealth managers. It operates in the United States, Europe, the Middle East, and Africa. Advent Software, Inc. was founded in 1983 and is headquartered in San Francisco, California.
ORTHOVITA INC (NASDAQ:VITA) - Orthovita, Inc., a specialty spine and orthopedic company, develops and markets orthobiologic and biosurgery products. The companys orthobiologics platform offers products for the fusion, regeneration, and fixation of human bone; and the biosurgery platform provides products for controlling intra-operative bleeding/hemostasis. Its orthobiologic product portfolio comprises Vitoss bone graft substitute, a high-porous resorbable beta-tricalcium phosphate bone graft substitute used to help the body guide the three-dimensional regeneration of the patients own bone; Bone Marrow Aspiration System with imbibe needles, syringes, and imbibe disposable delivery instrumentation, which provides spine and orthopedic surgeons with a method for harvesting a patients own bone marrow; Cortoss Bone Augmentation Material, a polymer composite for use in various surgical procedures to provide structural stability and reinforcement of the bones after surgery; and Aliquot Delivery System that facilitates delivery of materials to bony sites, including delivery of Cortoss product directly to the surgical site. The companys biosugery products include Vitagel surgical hemostat, a composite liquid hemostat that combines the biomaterials bovine thrombin and bovine collagen with the patients autologous plasma, and applied in the spine, hip, and knee replacement surgeries; and Vitasure Absorbable Hemostat, a plant-based hemostat product that can be deployed throughout surgery. It sells its products in the United States and internationally through a network of direct sales representatives and independent non-stocking distributors. The company has strategic partnerships with Kensey Nash Corporation; Angiotech Pharmaceuticals (U.S.), Inc.; and Medafor, Inc. Orthovita was founded in 1992 and is headquartered in Malvern, Pennsylvania.
M/I HOMES INC (NYSE:MHO) - M/I Homes, Inc., together with its subsidiaries, engages in the construction and sale of single-family residential properties. The company offers single-family homes, attached townhomes, and condominiums to first-time, move-up, empty-nester, and luxury buyers under the M/I Homes and Showcase Homes trade names. It designs, sells, and builds single-family homes on finished lots, which it develops or purchases ready for home construction. The company also purchases undeveloped land to develop into finished lots for construction of single-family homes and for sale to others. In addition, it provides mortgage financing services, such as originating mortgage loans, as well as offers title services to purchasers of its homes. Further, the company offers insurance services. M/I Homes, Inc. has operations in Columbus and Cincinnati, Ohio; Indianapolis, Indiana; Chicago, Illinois; Tampa and Orlando, Florida; Charlotte and Raleigh, North Carolina; and Virginia and Maryland suburbs of Washington, D.C. As of December 31, 2009, it had 2,410 developed lots and 664 lots under development in inventory, as well as owned raw land expected to be developed into approximately 4,121 lots. The company was founded in 1973 and is based in Columbus, Ohio.
GTX INC (NASDAQ:GTXI) - GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules to treat cancer, osteoporosis and bone loss, muscle loss, and other serious medical conditions. The company markets FARESTON (toremifene citrate) 60 mg tablets for the treatment of metastatic breast cancer in postmenopausal women through wholesale drug distributors in the United States. It is developing Toremifene citrate 80 mg, which completed pivotal Phase III clinical trial to reduce fractures and treat other estrogen deficiency side effects of androgen deprivation therapy in men with prostate cancer; and Toremifene 20 mg that is in pivotal Phase III clinical trial for the prevention of prostate cancer in high risk men with precancerous prostate lesions called high grade prostatic intraepithelial neoplasia. The company is also developing selective androgen receptor modulators comprising Ostarine, which completed Phase II clinical trials for the treatment of cancer cachexia and chronic sarcopenia; and GTx-758, an oral luteinizing hormone that completed two Phase I clinical trials for the treatment of advanced prostate cancer. It has a partnership agreement with Ipsen S.A. for the development and commercialization of toremifene 80 mg for the reduction of fractures in men with advanced prostate cancer on androgen deprivation therapy and toremifene 20 mg for the prevention of prostate cancer in patients with high grade prostatic intraepithelial neoplasia lesions. GTx, Inc. was founded in 1997 and is headquartered Memphis, Tennessee.
FINANCIAL INSTITUTIONS INC (NASDAQ:FISI) - Financial Institutions, Inc. operates as the holding company for Five Star Bank that provides consumer and commercial banking, and financial services to individuals, municipalities, and businesses in central and western New York. Its deposit accounts consist of noninterest-bearing demand, interest-bearing demand, savings, money market, club, individual retirement, and other qualified plan accounts, as well as certificates of deposit. The companys loan portfolio comprises commercial loans, commercial real estate loans, one-to-four family residential mortgages, consumer automobile loans, recreational vehicle loans, boat loans, home improvement loans, closed-end home equity loans, home equity lines of credit, collateralized and uncollateralized personal loans, deposit account collateralized loans, commercial and agricultural working capital and revolving lines of credit, commercial and agricultural mortgages, equipment loans, and crop and livestock loans. It operates through a network of approximately 51 offices and 70 ATMs in 14 contiguous counties of western and central New York. The company, through its other subsidiary, Five Star Investment Services, Inc., provides brokerage services. Financial Institutions, Inc. was founded in 1931 and is based in Warsaw, New York.
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact:
BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net